NYSEMKT:CANF
Can-Fite BioPharma Ltd Stock News
$1.98
+0.0100 (+0.508%)
At Close: Apr 19, 2024
Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol
07:00am, Friday, 05'th Mar 2021
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol
New Positive Data from Can-Fite's Liver Cancer Phase II Clinical Study with Namodenoson
07:10am, Monday, 22'nd Feb 2021
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory,
Piclidenoson From Can-Fite Biopharma Shows New, Promising Developments For Psoriasis Treatment
01:26pm, Tuesday, 19'th Jan 2021
Can-Fite Biopharma Ltd. was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020.
Can-Fite to Present at Biotech Showcase Digital 2021
07:00am, Monday, 04'th Jan 2021
Petach Tikva, Israel--(Newsfile Corp. - January 4, 2021) - Can-Fite BioPharma Ltd. (NYSE: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that addre
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflamma
Can-Fite BioPharma Ltd. (CANF) CEO Pnina Fishman on Q3 2020 Results - Earnings Call Transcript
11:43am, Monday, 30'th Nov 2020
Can-Fite BioPharma Ltd. (CANF) CEO Pnina Fishman on Q3 2020 Results - Earnings Call Transcript
7 Biotech Penny Stocks Worth a Gamble
11:50am, Wednesday, 11'th Nov 2020
With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved. The post 7 Biotech
Eli Lilly Jardiance Data, And Other News: The Good, Bad And Ugly Of Biopharma
10:30pm, Thursday, 03'rd Sep 2020
Eli Lilly offers positive data for Jardiance in treating cardiovascular issues. Can-Fite moves forward with Piclidenoson for COVID-19.
Can-Fite BioPharma (CANF) Investor Presentation - Slideshow
05:14pm, Friday, 28'th Aug 2020
The following slide deck was published by Can-Fite BioPharma Ltd. in conjunction with this event..
Can-Fite BioPharma Ltd. (CANF) CEO Pnina Fishman on Q2 2020 Results - Earnings Call Transcript
09:51pm, Thursday, 27'th Aug 2020
Can-Fite BioPharma Ltd. (NYSEMKT:CANF) Q2 2020 Earnings Conference Call August 27, 2020 04:15 PM ET Company Participants Pnina Fishman - Chief Executive Officer Motti Farbstein - Chief Financial Offic
Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors
08:12am, Saturday, 22'nd Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
LD Micro - Announces Preliminary List of Presenters for the LD-500
01:00pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
11:00am, Monday, 27'th Jul 2020
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
11:00am, Monday, 20'th Jul 2020
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
11:00am, Wednesday, 15'th Jul 2020
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
